Parkside Financial Bank & Trust’s Vera Therapeutics VERA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.89K	Buy	44 +4	+10%	+$149	﹤0.01%	2197
2026 Q1	$1.61K	Buy	40 +2	+5%	+$86	﹤0.01%	2199
2025 Q4	$1.93K	Buy	38 +13	+52%	+$462	﹤0.01%	2110
2025 Q3	$727	Buy	25 +5	+25%	+$116	﹤0.01%	2401
2025 Q2	$472	Hold	20	–	–	﹤0.01%	2583
2025 Q1	$481	Buy	+20	New	+$643	﹤0.01%	2424

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Parkside Financial Bank & Trust's VERA Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its Vera Therapeutics (VERA) stake by 10% in Q2 2026, buying an estimated $149 and bringing the position to 44 shares worth $1.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

Parkside Financial Bank & Trust first reported a position in VERA in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.93K in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Parkside Financial Bank & Trust held 44 shares of Vera Therapeutics worth $1.89K as of Q2 2026.
Parkside Financial Bank & Trust bought 4 Vera Therapeutics shares in Q2 2026, an estimated $149.
Vera Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2197 holding.
Parkside Financial Bank & Trust first reported a position in Vera Therapeutics in Q1 2025 and has held it in 6 quarters since.
Parkside Financial Bank & Trust's Vera Therapeutics position peaked at $1.93K in Q4 2025.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.